EfA Technologies

📍 Yokneam Ilit, Israel🗓 Founded 2016👥 13 employees💰 Last funded Oct 2018
We designed a portable, affordable and easy to use hematology lab, which provides instant results like CBC, complete blood count. The platform technology houses multiple clinical applications and has an AI based microscope. It reduces cost, time and it improves the doctor-patient experience. EFA brings the LAB to the BLOOD and not the BLOOD to the LAB without the need for an expert preparation. EfA is changing the diagnostics paradigm step by step by enabling tests which were ONLY available in the labs/clinics/hospitals etc. to be done ANYTIME and EVERYWHERE. An early and rapid diagnostic is a key to the prevention of overuse and improper medications. Many millions of people cannot access a proper diagnostic due to their medical condition and/or where they live. Bringing as many as possible medical services closer to them, will make a huge impact on how we manage health around the world. The initial application of a complete blood count everywhere will give results in less than 5 minutes ON THE DEVICE. EfA also creates a marketplace for developers, partners and researches adding health-apps for various conditions and future diagnostic needs. EfA's RevDx portable device realtime analysis enables telemedicine applications.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2016
Founded
Investor geography1 country
Israel
2
Frequently asked questions
Who invested in EfA Technologies?
EfA Technologies has 2 investors on record on gritt.io, including 2 early-stage backers.
When did EfA Technologies last raise funding?
The most recent investment in EfA Technologies recorded on gritt.io was in October 2018.
When was EfA Technologies founded?
EfA Technologies was founded in 2016.
What industry is EfA Technologies in?
EfA Technologies operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is EfA Technologies based?
EfA Technologies is headquartered in Yokneam Ilit, Israel.